Trending...
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- New Mobile Car Detailing Platform Connects Drivers with On-Demand Local Pros
- Cal State LA secures funding for two artificial intelligence projects from CSU
SAN FRANCISCO ~ In a recent announcement, CIBC Innovation Banking revealed that it has provided growth financing to InsightRX, a San Francisco-based software company. InsightRX is known for its innovative use of quantitative pharmacology and artificial intelligence (AI) to enhance therapeutic decision-making from the early stages of drug development to the point of patient care.
InsightRX's unique approach involves utilizing patient-specific data and quantitative models to tailor dosing for complex treatments such as antibiotics, chemotherapeutic agents, and immunosuppressants. By incorporating AI technology, the company also empowers data scientists in analyzing clinical trial data, aiding in trial design, understanding dose-exposure-response relationships, and refining dosing strategies for regulatory submissions.
According to Sirj Goswami, Ph.D., CEO and co-founder of InsightRX, their goal is to shift away from the traditional "one-size-fits-all" approach in drug dosing towards a more individualized treatment paradigm. This not only benefits patient care but also has a significant impact on the introduction of new drugs to the market. To achieve their strategic vision of transforming patient care, InsightRX sought out financing from CIBC and found them to be an ideal partner due to their intellectual curiosity about the intricacies of their business and thoughtful approach.
More on The Californer
John Flemming, managing director of CIBC Innovation Banking's Seattle office expressed excitement about working with InsightRX's leadership team. He believes that their use of AI technology will pave the way for advancements in drug development within biopharma clinical trials and improve healthcare providers' ability to ensure optimal drug dosing for patients. Flemming also noted that InsightRX will play a crucial role in enhancing the development of new therapies that prioritize patient safety throughout the healthcare drug development and delivery chain.
With this new financing from CIBC Innovation Banking, InsightRX is well-positioned to continue its groundbreaking work in revolutionizing drug dosing and improving patient outcomes. As they continue to lead the way in this field, InsightRX and CIBC are poised to make a significant impact on the future of healthcare.
InsightRX's unique approach involves utilizing patient-specific data and quantitative models to tailor dosing for complex treatments such as antibiotics, chemotherapeutic agents, and immunosuppressants. By incorporating AI technology, the company also empowers data scientists in analyzing clinical trial data, aiding in trial design, understanding dose-exposure-response relationships, and refining dosing strategies for regulatory submissions.
According to Sirj Goswami, Ph.D., CEO and co-founder of InsightRX, their goal is to shift away from the traditional "one-size-fits-all" approach in drug dosing towards a more individualized treatment paradigm. This not only benefits patient care but also has a significant impact on the introduction of new drugs to the market. To achieve their strategic vision of transforming patient care, InsightRX sought out financing from CIBC and found them to be an ideal partner due to their intellectual curiosity about the intricacies of their business and thoughtful approach.
More on The Californer
- Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Wise Business Plans Emerges as a Go-To Partner for Angel Investors, VCs, Family Offices and Private
- Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
- Neurocrine Biosciences Presents One-Year Data Showing Sustained Efficacy of CRENESSITY® (crinecerfont) in Adult Patients, at ENDO 2025
- Mike Diamond Offers $775 Off Full Heating & A/C Installation for a Limited Time
John Flemming, managing director of CIBC Innovation Banking's Seattle office expressed excitement about working with InsightRX's leadership team. He believes that their use of AI technology will pave the way for advancements in drug development within biopharma clinical trials and improve healthcare providers' ability to ensure optimal drug dosing for patients. Flemming also noted that InsightRX will play a crucial role in enhancing the development of new therapies that prioritize patient safety throughout the healthcare drug development and delivery chain.
With this new financing from CIBC Innovation Banking, InsightRX is well-positioned to continue its groundbreaking work in revolutionizing drug dosing and improving patient outcomes. As they continue to lead the way in this field, InsightRX and CIBC are poised to make a significant impact on the future of healthcare.
Filed Under: Business
0 Comments
Latest on The Californer
- Montana-Inspired Music Team Scores Multiple International Nominations
- Mike Diamond Offers Free Sewer Camera Inspections to Help Homeowners Catch Problems Early
- Mike Diamond Offers $99 Priority & Premium Air Conditioning Protection in Anaheim, CA
- Garmin Approach R50: Redefining Home Golf Simulation
- California: Governor Newsom statement on the court temporarily blocking the Trump Administration's unlawful immigration tactics in the Los Angeles area
- Governor Newsom urges Californians to take precautions as state endures triple digit heat, smoky conditions
- Yvette Kendall Secures $6 Million Deal with The Sessions Studios for Horror Thriller, "NORTH"
- Buy The Crave Launches Premium Creatine and Natural Wellness Supplements for Modern Lifestyles
- Long Beach Parks, Recreation and Marine's Homeland Cultural Center Presents DanceFest at Cesar Chavez Park Amphitheater on August 16
- Sisu, a Portrait of Grit, Connection and Triumph, Premieres on Documentary Showcase
- New Liz Taylor Book Coming Soon: Chasing Elizabeth Taylor
- City of Long Beach Experienced a 4% Decrease in Fireworks-Related Reports on July 4
- The Blue Luna Encourages Local Schools to Take Steps to Enhance Safety for Students and Staff
- Wise Business Plans Launches Turnkey Startup Packages to Help Entrepreneurs Start and Scale
- CarSeek Re-Launch: A New Look, A Better Experience for Car Buyers
- California: Governor Newsom provides $11 million to organizations helping underserved job seekers find training and employment
- For Artificial Intelligence Appreciation Day: Celebrate it with a poem about AI called "Robot Love"
- City of Long Beach Shares Federal Funding Updates and Local Impacts
- The Sessions Studios Secures $300 Million Commitment to Launch World-Class Studio and 15-Film Global Slate
- Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit